Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

/p>

Diluted (1) $(0.10) $(0.10) $0.52

Weighted average shares

outstanding:

Basic 267,276

Diluted (1) 285,208

(1) GAAP As-Reported diluted earnings per share and diluted weighted

average shares outstanding reflect the adoption of EITF 04-8. In

accordance with the provisions of EITF 04-8, interest and debt fees

related to our 1.25% convertible senior notes of $1,886K, net of tax,

have been added back to net income and approximately 9,686K shares

have been added to diluted weighted average shares for purposes of

computing GAAP As-Reported diluted earnings per share.

GENZYME 2008 GUIDANCE

April 21, 2008 Guidance

DESCRIPTION Ranges

Renagel / Renvela $690 $700

Total Renal 800 815

Cerezyme 1,215 1,240

Fabrazyme 495 505

Myozyme 275 285

Aldurazyme 135 145

Total Therapeutics 2,325 2,385

Total Transplant 210 220

Synvisc 270 280

Total Biosurgery 490 505

Total Diag/Genetics 475 485

Total Other 260 270

TOTAL REVENUE
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has ... Promising Pharma and Life Science Technology Solution Providers 2015. ... software platform for life sciences companies. , The ... of experts and members of CIO Review’s editorial board ... has been on our radar for some time now ...
(Date:4/17/2015)... April 17, 2015 LC Sciences ... technologies, announced today that it is seeking beta ... innovative multiplex PCR based targeted sequencing technology. The ... analysis, that enables accurate detection of rare variants. ... Omega-Primer™ technologies. The company will collaborate with beta ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Cytokinetics, Incorporated ... report first quarter results on Thursday, April 30, 2015 ... senior management will host a conference call at 4:30 ... and the company’s outlook for the future. , The ... accessed from the homepage and in the Investor Relations ...
(Date:4/16/2015)... According to the 2014 Liberty ... source was ranked first among the leading causes ... lifting, pushing, pulling, holding, carrying, or throwing and ... David Round Company takes statistics like this very ... to develop and design equipment that prevents these ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2
... BEIJING , Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED ), a ... in March 2010 : , , Investor Conference ... Location, Rodman & Renshaw Annual March 7-9, 2010 ... ...
... , , NEW YORK , ... firm specializing in investor relations and corporate communications for domestic ... and Matthew Haines have joined as Managing Directors. ... corporate experience that will serve our clients well,” said ...
... , , , , ... -- 3SBio Inc. (Nasdaq:, SSRX ) ("3SBio" or "the ... researching, developing, manufacturing and marketing,biopharmaceutical products, today announced a ... and commercialize its,Nephoxil(R) pharmaceutical product for the treatment of ...
Cached Biology Technology:China Medical Technologies to Participate Investor Conferences in March 2010 2MBS Value Partners Hires Two New Senior Staff Members 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Research at the University of Liverpool has found that Shakespearean ... bard's plays and poetry. , Shakespeare uses a linguistic technique ... noun to serve as a verb. Researchers found that ... means before it understands the function of the word within ...
... of children is effectively an estimate of the probability ... a new study recently published in Journal of Vision, ... Research in Vision and Ophthalmology (ARVO). , Participants ... half of which portrayed actual siblings. In one ...
... in the world. Half the country is arid or ... are scarce. Yet 1.3 billion people live in China, ... At the same time, China's environmental problems of energy and ... are escalating. , The September issue of Frontiers ...
Cached Biology News:Reading Shakespeare has dramatic effect on human brain 2China's environmental challenges 2
Without sodium bicarbonate. Sterile, Cell culture tested...
... immunospot) Kit analyzes interferon gamma (IFNγ) production ... forms at the site where secreted cytokine ... dissection microscope or automated ELISPOT reader) and ... added to the microplate. This allows the ...
... This CLS number is ... created to easily match ... showing no availability yet, ... old Sigma-Aldrich number (Z71,515-8) ...
... of your microarray data using Asuragens bioinformatics ... from consultation to extensive data analysis using ... our expertise in combination with the Gene ... microarray experiments., ,Normalization and basic statistical analysis ...
Biology Products: